Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Blazing

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Heart Disease and Stroke : a Journal for Primary Care Physicians|March 11, 1992
Atrial fibrillation: conventional wisdom reappraisedM A Blazing, J J Morris
Current Opinion in Cardiology|August 17, 1999
Evidence supporting secondary prevention strategiesM A Blazing, C M O'Connor
Biochemistry|November 22, 1983
Lipid-protein interactions in reconstituted membranes containing acetylcholine receptorJ F Ellena, M A Blazing, M G McNamee
American Heart Journal|October 28, 1999
Atherosclerotic disease in non-insulin-dependent diabetes mellitus: role of abnormal lipids and the place for lipid-altering therapiesD G Orloff, M A Blazing, C M O'Connor
Hospital Practice (1995)|April 26, 2000
Advances in the approach to acute coronary syndromesD F Kong, M A Blazing, C M O'Connor
Heart (British Cardiac Society)|March 1, 1996
Vascular gene transferK M Channon, M A Blazing, S E George
Cardiology Clinics|June 29, 1999
The health care burden of unstable anginaD F Kong, M A Blazing, C M O'Connor
The Journal of Biological Chemistry|December 8, 1995
The calmodulin-nitric oxide synthase interaction. Critical role of the calmodulin latch domain in enzyme activationZ Su, M A Blazing, D Fan, et al.
Cardiovascular Research|November 1, 1996
Adenoviral gene transfer of nitric oxide synthase: high level expression in human vascular cellsK M Channon, M A Blazing, G A Shetty, et al.
American Heart Journal|August 2, 2001
The A-to-Z Trial: Methods and rationale for a single trial investigating combined use of low-molecular-weight heparin with the glycoprotein IIb/IIIa inhibitor tirofiban and defining the efficacy of early aggressive simvastatin therapyM A Blazing, J A De Lemos, C K Dyke, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Heart Disease and Stroke : a Journal for Primary Care Physicians|March 11, 1992
Atrial fibrillation: conventional wisdom reappraisedM A Blazing, J J Morris
Current Opinion in Cardiology|August 17, 1999
Evidence supporting secondary prevention strategiesM A Blazing, C M O'Connor
Biochemistry|November 22, 1983
Lipid-protein interactions in reconstituted membranes containing acetylcholine receptorJ F Ellena, M A Blazing, M G McNamee
American Heart Journal|October 28, 1999
Atherosclerotic disease in non-insulin-dependent diabetes mellitus: role of abnormal lipids and the place for lipid-altering therapiesD G Orloff, M A Blazing, C M O'Connor
Hospital Practice (1995)|April 26, 2000
Advances in the approach to acute coronary syndromesD F Kong, M A Blazing, C M O'Connor
Heart (British Cardiac Society)|March 1, 1996
Vascular gene transferK M Channon, M A Blazing, S E George
Cardiology Clinics|June 29, 1999
The health care burden of unstable anginaD F Kong, M A Blazing, C M O'Connor
The Journal of Biological Chemistry|December 8, 1995
The calmodulin-nitric oxide synthase interaction. Critical role of the calmodulin latch domain in enzyme activationZ Su, M A Blazing, D Fan, et al.
Cardiovascular Research|November 1, 1996
Adenoviral gene transfer of nitric oxide synthase: high level expression in human vascular cellsK M Channon, M A Blazing, G A Shetty, et al.
American Heart Journal|August 2, 2001
The A-to-Z Trial: Methods and rationale for a single trial investigating combined use of low-molecular-weight heparin with the glycoprotein IIb/IIIa inhibitor tirofiban and defining the efficacy of early aggressive simvastatin therapyM A Blazing, J A De Lemos, C K Dyke, et al.
Pageof 2